Endovia Health Sciences Capital Expenditures (CapEx) Growth & History (EDVA)

Endovia Health Sciences's capital expenditures (capex) was $3,235 for fiscal 2024.

View full Endovia Health Sciences company overview

Endovia Health Sciences annual capital expenditures (capex) history

Endovia Health Sciences annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20242024-12-31$3,235−$10,878−77.08%
20232023-12-31$14,113−$88,585−86.26%
20222022-12-31$102,698$102,698
20212021-12-31$0−$91,066
20202020-12-31$91,066$78,514+625.51%
20192019-12-31$12,552−$63,081−83.40%
20182018-12-31$75,633$17,358+29.79%
20172017-12-31$58,275−$149−0.26%
20162016-12-31$58,424$31,544+117.35%
20152015-12-31$26,880−$3,507−11.54%
20142014-12-31$30,387

Endovia Health Sciences capital expenditures (capex) trends

Over the last five fiscal years, Endovia Health Sciences's capital expenditures (capex) decreased from $12,552 to $3,235, a change of −$9,317. The latest reported quarter, Q3 2024, shows $3,235.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Endovia Health Sciences source filings ↗

Community posts

It’s quiet here.

No posts about EDVA yet. Start the conversation.

Write the first post